NLRP3 and ovarian carcinoma: This effect is mechanistically distinct from galangin, which suppresses aberrant NLRP3 activation in ovarian cancer xenograft mouse models, downregulating both NLRP3 expression and IL-1β maturation (Hoesel and Schmid, 2013).